Assembly Pharmaceuticals Inc., Ventrus Biosciences Inc. deal

The companies will merge in a stock deal. Assembly shareholders will receive 20.3 million Ventrus shares valued at $23.2 million based on Ventrus' close of $1.06 on May 16, the last trading day before...